首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1109601篇
  免费   76852篇
  国内免费   1408篇
耳鼻咽喉   15541篇
儿科学   35613篇
妇产科学   29735篇
基础医学   158694篇
口腔科学   30553篇
临床医学   99442篇
内科学   209560篇
皮肤病学   24891篇
神经病学   84479篇
特种医学   44576篇
外国民族医学   202篇
外科学   167944篇
综合类   22397篇
现状与发展   1篇
一般理论   284篇
预防医学   78701篇
眼科学   25303篇
药学   88990篇
  9篇
中国医学   2838篇
肿瘤学   68108篇
  2019年   8301篇
  2018年   11928篇
  2017年   9436篇
  2016年   10622篇
  2015年   11860篇
  2014年   16069篇
  2013年   23475篇
  2012年   32395篇
  2011年   34172篇
  2010年   19973篇
  2009年   18684篇
  2008年   31539篇
  2007年   33776篇
  2006年   34434篇
  2005年   32758篇
  2004年   31282篇
  2003年   29979篇
  2002年   29027篇
  2001年   61203篇
  2000年   62729篇
  1999年   52027篇
  1998年   12967篇
  1997年   11421篇
  1996年   11427篇
  1995年   10702篇
  1994年   9666篇
  1993年   9182篇
  1992年   38729篇
  1991年   37171篇
  1990年   36659篇
  1989年   35137篇
  1988年   31640篇
  1987年   30739篇
  1986年   28940篇
  1985年   27173篇
  1984年   19739篇
  1983年   16590篇
  1982年   9146篇
  1979年   17526篇
  1978年   11829篇
  1977年   10520篇
  1976年   9156篇
  1975年   10360篇
  1974年   12023篇
  1973年   11643篇
  1972年   11145篇
  1971年   10460篇
  1970年   9570篇
  1969年   9191篇
  1968年   8132篇
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
81.
82.

Objective

Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.

Methods

From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.

Results

Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).

Conclusions

Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes.  相似文献   
83.
84.
85.
86.
87.
88.
89.
90.
Epigenetics refers broadly to processes that influence medium to long‐term gene expression by changing the readability and accessibility of the genetic code. The Neurobiology Commission of the International League Against Epilepsy (ILAE) recently convened a Task Force to explore and disseminate advances in epigenetics to better understand their role and intersection with genetics and the neurobiology of epilepsies and their co‐morbidities, and to accelerate translation of these findings into the development of better therapies. Here, we provide a topic primer on epigenetics, explaining the key processes and findings to date in experimental and human epilepsy. We review the growing list of genes with epigenetic functions that have been linked with epilepsy in humans. We consider potential practical applications, including using epigenetic signals as biomarkers for tissue‐ and biofluid‐based diagnostics and the prospects for developing epigenetic‐based treatments for epilepsy. We include a glossary of terms, FAQs and other supports to facilitate a broad understanding of the topic for the non‐expert. Last, we review the limitations, research gaps and the next challenges. In summary, epigenetic processes represent important mechanisms controlling the activity of genes, providing opportunities for insight into disease mechanisms, biomarkers and novel therapies for epilepsy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号